Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Merlo

Showing results (411-420 of 432) with videos related to

Pageof 44
Sort By:
European Journal of Heart Failure|March 12, 2023
Diagnostic pathways to wild-type transthyretin amyloid cardiomyopathy: a multicentre network studyGiacomo Tini, Paolo Milani, Mattia Zampieri, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|February 17, 2026
Acute coronary syndrome and coronary artery disease in wild-type transthyretin amyloid cardiomyopathy: a DIAMOND sub-studyLaura De Michieli, Giacomo Tini, Alessia Argirò, et al.
JACC. Heart Failure|July 3, 2025
Outcome and Disease Progression in NYHA Functional Class I and II Patients With Wild-Type Transthyretin Cardiomyopathy Treated With TafamidisGiulio Sinigiani, Giuseppe Damiano Sanna, Alberto Aimo, et al.
Medrxiv : the Preprint Server for Health Sciences|August 8, 2025
The contribution of <i>RBM20</i> truncating variants to human cardiomyopathyBrendan J Floyd, Joyce N Njoroge, Vikki A Krysov, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|November 26, 2025
Neurohormonal therapies at baseline and follow-up and survival in wild-type transthyretin cardiac amyloidosisAlberto Aimo, Paolo Milani, Giacomo Tini, et al.
JACC. Advances|May 13, 2025
The Diagnostic and Prognostic Value of the 12-Lead ECG in Arrhythmogenic Left Ventricular CardiomyopathyLeonardo Calò, Cinzia Crescenzi, Andrea Di Marco, et al.
JAMA Cardiology|April 8, 2026
RBM20 Truncating Variants and Human CardiomyopathyBrendan J Floyd, Joyce N Njoroge, Vikki A Krysov, et al.
Circulation. Genomic and Precision Medicine|July 8, 2026
Variant Site-Specific Natural History of Titin-Induced Cardiomyopathy: An International Multicenter RegistryMaria Perotto, Cinzia Radesich, Alessia Paldino, et al.
Mayo Clinic Proceedings|August 6, 2021
Rapid Exclusion of COVID Infection With the Artificial Intelligence ElectrocardiogramZachi I Attia, Suraj Kapa, Jennifer Dugan, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|June 27, 2025
Myosin-ATPase inhibitor in real-world patients with obstructive HCM: a report by the Cardiomyopathies and Pericardial Diseases WG of the Italian Society of CardiologyCesare de Gregorio, Paolo Bellocchi, Anna Rosa Napoli, et al.
Pageof 44

Showing results (411-420 of 432) with videos related to

Sort By:
Pageof 44
European Journal of Heart Failure|March 12, 2023
Diagnostic pathways to wild-type transthyretin amyloid cardiomyopathy: a multicentre network studyGiacomo Tini, Paolo Milani, Mattia Zampieri, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|February 17, 2026
Acute coronary syndrome and coronary artery disease in wild-type transthyretin amyloid cardiomyopathy: a DIAMOND sub-studyLaura De Michieli, Giacomo Tini, Alessia Argirò, et al.
JACC. Heart Failure|July 3, 2025
Outcome and Disease Progression in NYHA Functional Class I and II Patients With Wild-Type Transthyretin Cardiomyopathy Treated With TafamidisGiulio Sinigiani, Giuseppe Damiano Sanna, Alberto Aimo, et al.
Medrxiv : the Preprint Server for Health Sciences|August 8, 2025
The contribution of <i>RBM20</i> truncating variants to human cardiomyopathyBrendan J Floyd, Joyce N Njoroge, Vikki A Krysov, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|November 26, 2025
Neurohormonal therapies at baseline and follow-up and survival in wild-type transthyretin cardiac amyloidosisAlberto Aimo, Paolo Milani, Giacomo Tini, et al.
JACC. Advances|May 13, 2025
The Diagnostic and Prognostic Value of the 12-Lead ECG in Arrhythmogenic Left Ventricular CardiomyopathyLeonardo Calò, Cinzia Crescenzi, Andrea Di Marco, et al.
JAMA Cardiology|April 8, 2026
RBM20 Truncating Variants and Human CardiomyopathyBrendan J Floyd, Joyce N Njoroge, Vikki A Krysov, et al.
Circulation. Genomic and Precision Medicine|July 8, 2026
Variant Site-Specific Natural History of Titin-Induced Cardiomyopathy: An International Multicenter RegistryMaria Perotto, Cinzia Radesich, Alessia Paldino, et al.
Mayo Clinic Proceedings|August 6, 2021
Rapid Exclusion of COVID Infection With the Artificial Intelligence ElectrocardiogramZachi I Attia, Suraj Kapa, Jennifer Dugan, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|June 27, 2025
Myosin-ATPase inhibitor in real-world patients with obstructive HCM: a report by the Cardiomyopathies and Pericardial Diseases WG of the Italian Society of CardiologyCesare de Gregorio, Paolo Bellocchi, Anna Rosa Napoli, et al.
Pageof 44